common side effects of glp-1 receptor agonists Clinical Recommendations to Manage Gastrointestinal

However, the coexistence of micro and macrovascular disease is associated with the highest cardiovascular risks which highlights the importance that pharmacological treatment of type 2 diabetes mellitus provides not only glycemic control, but also cardiovascular safety

The incretin system has become an important target in the treatment of type 2 diabetes in recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose-lowering effects

Specifically, the primary care data can be requested via application to the CPRD ().

Basal insulin is a highly effective treatment in reducing fasting blood glucose, but it is associated with considerable risk of hypoglycemia and weight gain

*Based on preclinical studies, can support your bodys natural GLP-1 production